JY
KTOVW

Jeff Yass’s Kitov Pharma Ltd. Warrants KTOVW Stock Holding History

Jeff Yass’s Portfolio KTOVW Stock Details KTOVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,352
Closed -$6K – 11449
2020
Q2 		$6K Buy
+30,352
New +$1.74K ﹤0.01% 10005
2020
Q1 		– Sell
-79,571
Closed -$5K – 11218
2019
Q4 		$5K Sell
79,571
-13,786
-15% -$885 ﹤0.01% 9580
2019
Q3 		$10K Sell
93,357
-5,910
-6% -$719 ﹤0.01% 10023
2019
Q2 		$11K Buy
99,267
+32,926
+50% +$5.23K ﹤0.01% 10070
2019
Q1 		$13K Buy
+66,341
New +$14.9K ﹤0.01% 8639
2018
Q2 		– Sell
-11,188
Closed -$7K – 10770
2018
Q1 		$7K Buy
+11,188
New +$8.03K ﹤0.01% 9191
2017
Q4 		– Sell
-20,027
Closed -$14K – 10182
2017
Q3 		$14K Sell
20,027
-7,864
-28% -$4.37K ﹤0.01% 8676
2017
Q2 		$12K Buy
27,891
+14,358
+106% +$6.61K ﹤0.01% 9065
2017
Q1 		$7K Sell
13,533
-37,270
-73% -$28.1K ﹤0.01% 8791
2016
Q4 		$68K Buy
+50,803
New +$76.9K ﹤0.01% 9207

Other funds holding KTOVW

CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jeff Yass's KTOVW Position: Q3 2020 in Review

Jeff Yass sold out of Kitov Pharma Ltd. Warrants (KTOVW) in Q3 2020, closing a stake of 30,352 shares — an estimated $6K sold.

Jeff Yass first reported a position in KTOVW in Q4 2016 and held it in 10 quarters. The position peaked at $68K in Q4 2016. 4 funds tracked by Wall St. Rank hold KTOVW as of Q3 2020.

  • Jeff Yass reported no remaining Kitov Pharma Ltd. Warrants position as of Q3 2020 after selling out during the quarter.
  • Jeff Yass sold 30,352 Kitov Pharma Ltd. Warrants shares in Q3 2020, an estimated $6K.
  • Jeff Yass first reported a position in Kitov Pharma Ltd. Warrants in Q4 2016 and held it in 10 quarters.
  • Jeff Yass's Kitov Pharma Ltd. Warrants position peaked at $68K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Kitov Pharma Ltd. Warrants as of Q3 2020.

Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.